A Phase I/II Trial of Radiotherapy Concurrent with TS-1 Plus Cisplatin in Patients with Clinically Resectable Type 4 or Large Type 3 Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205

Author： Imano Motohiro   Furukawa Hiroshi   Yokokawa Masaki   Nishimura Yasumasa   Kurokawa Yukinori   Satoh Taroh   Sakai Daisuke   Yasuda Takushi   Imamoto Haruhiko   Tujinaka Toshimasa   Shimokawa Toshio   Shiozaki Hitoshi  

Publisher： Oxford University Press

ISSN： 1465-3621

Source： Japanese Journal of Clinical Oncology, Vol.43, Iss.4, 2013-04, pp. : 431-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II study of induction chemotherapy plus concurrent chemotherapy and SMART-IMRT-based radiotherapy in locoregionally-advanced nasopharyngeal cancer

By                  

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 889-895

Spandidos Publications

Access to resources Recommend Favorite

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

By Kim Jong   Sohn Sang   Song Hong   Kwon Ki-Young   Do Young   Lee Kyung   Hyun Myung   Ryoo Hun   Bae Sung   Park Keon   Baek Jin   Lee Won   Chung Joo   Cho Goon   Sohn Chang-Hak   Jang Jung   Chung Ho   Yu Wansik  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with -interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial

By Wagener D.J.T.   Wils J.A.   Kok T.C.   Planting A.   Couvreur M.L.   Baron B.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 648-653

Elsevier

Access to resources Recommend Favorite

Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer

By                                

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1297-1304

Spandidos Publications

Access to resources Recommend Favorite

A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer

By Yamada Yasuhide   Kiyota Naomi   Fuse Nozomu   Kato Ken   Minami Hironobu   Hashizume Kensei   Kuroki Yoshihiro   Ito Yuichiro   Ohtsu Atsushi  

Gastric Cancer, Vol. 17, Iss. 1, 2014-01 ,pp. : 161-172

Springer Publishing Company

Access to resources Recommend Favorite